Atrium Therapeutics, Inc. · NASDAQ:RNA
Hoyos Rocio Martin received 30,000 Atrium Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 20, 2026 · Filed Apr 22, 2026
On Apr 20, 2026, Hoyos Rocio Martin (Chief Strategy Officer) received 30,000 Atrium Therapeutics, Inc. shares as an award, leaving 46,660 shares. Filed Apr 22, 2026 (Form 4).
- Awarded
- 30,000 shares
- Holding after
- 46,660 shares
- Trading plan
- No
- Role
- Chief Strategy Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | Award | 30,000 | 46,660 | Direct |
Source
Related
- Atrium Therapeutics, Inc.
- Hoyos Rocio Martin
- Atrium Therapeutics, Inc. shareholders
- Form 4 · Hoyos Rocio Martin · Sep 22, 2026
- Form 4 · Younis Husam · Sep 22, 2026
- Form 4 · Hughes Steven George · Sep 22, 2026
- Form 4 · Flanagan W. Michael · Sep 22, 2026
- Form 4 · Boyce Sarah · Sep 22, 2026
- Form 4 · Kenney Stephanie · Sep 22, 2026